Welcome to the ESPID 2021 Meeting Calendar
The Meeting will officially run on CEST (GMT + 2 / UTC + 2)
To convert the meeting times to your local time Click Here
The viewing of sessions cannot be accessed from this conference calendar. All sessions are accessible via the Main Lobby at the Virtual Platform.
Icons Legend: - Live Session - On Demand Session - On Demand with Live Q&A - Live ESPID Show
COVID-19: The Generational Divide - Supported by Janssen Pharmaceuticals
Join our expert faculty at this live satellite symposium, which will be examining the current COVID-19 vaccines landscape. Key topics of discussion will include an overview on epidemiology, current variants of concern, transmission chains and ongoing paediatric investigational plans. Our expert faculty includes our co-chairs Professor Vana Papaevangelou, Professor of Paediatric Infectious Diseases at the University of Athens School of Medicine, and Professor Susanna Esposito, Professor of Paediatrics at the University of Parma. Our co-chairs will also be supported by Dr. Mika Rämet, Professor of Paediatrics and Director of the Tampere University Vaccine Research Centre. The symposium will end with a live Q&A session led by our faculty, to support scientific exchange with the audience and the panel.
If you have any medical information enquiries regarding any Janssen products, please contact Janssen at: https://www.jamie-system.com/event/9361
1620 - YOUR NETWORKING BREAK-VISIT EXHIBITION | E-POSTER VIEWING | CHAT ROOMS | (ID 2)
LET’S TALK ABOUT RSV – A Risk For Every Infant - Supported by Sanofi Pasteur
This Sanofi-sponsored symposium consists of a series of talks to help raise awareness around RSV (respiratory syncytial virus) and to better equip physicians with key information on the impact of this disease on all infants. The session will take the form of a news broadcast where key medical experts will share their personal insights in RSV, and real-life experience on the front lines with interviews from a parent and a paediatric ICU nurse, all moderated by medical journalist Dr Mark Porter.
1650 - YOUR NETWORKING BREAK-VISIT EXHIBITION | E-POSTER VIEWING | CHAT ROOMS | (ID 4)
PCV Effectiveness in Children: Understanding Issues in Serotype-Specific Vaccine Impact - Supported by Pfizer
Our symposium will summarize available evidence on serotype-specific vaccine effectiveness and impact and highlight the newest evidence exploring unique characteristics of individual serotypes and what they mean for vaccine impact.
1670 - YOUR NETWORKING BREAK-VISIT EXHIBITION | E-POSTER VIEWING | CHAT ROOMS | (ID 7)
Are there lessons of meningococcal disease lurking in the shadows of the last 100 years? - Supported by Pfizer
This symposium will explore how past world events have influenced meningococcal disease and the role of vaccines in defeating this disease through:
• Reviewing the epidemiology of meningococcal disease over the last 100 years, focusing on lessons for the future.
• Highlighting the key pillars for the global strategy to defeat meningitis by 2030.
• Exploring current vaccine characteristics informing meningococcal vaccine implementation.
1690 - YOUR NETWORKING BREAK-VISIT EXHIBITION | E-POSTER VIEWING | CHAT ROOMS | (ID 9)
4CMenB: from evidence to vaccination - Supported by GlaxoSmithKline Biologicals SA
The current level of evidence from 4CMenB safety, impact, and effectiveness has demonstrated that the vaccine consistently reduces invasive meningococcal B disease (MenB) across the most vulnerable age groups and in various settings. Prof Federico Martinón-Torres will be chairing the symposium, recent evidence from both infants and adolescents will be presented from Australia by Prof Helen Marshall, and the clinical relevance of these data and the evolution of meningococcal immunization programmes with MenB in Europe will be discussed by Prof Paolo Bonanni.
Pediatric pneumococcal disease: Today’s reality and future opportunities for disease prevention - Supported by MSD
The objectives of the Symposium are to provide participants with an understanding of:
1. Trends in the epidemiology of breakthrough and residual disease in both healthy and at-risk children, including the impact of the COVID-19 pandemic.
2. Dynamics of nasopharyngeal carriage among children and implications for pneumococcal vaccine impact.
3. Potential challenges for next generation PCVs and the key attributes needed to have a broad public health impact.
1720 - YOUR NETWORKING BREAK-VISIT EXHIBITION | E-POSTER VIEWING | CHAT ROOMS | (ID 12)
Pediatric immunization: Opportunities and challenges - Supported by MSD
Satellite Symposium will aim to share information and data on burden of pediatric diseases, impact of vaccination and criteria for implementing and executing successful immunization programs. The symposium will feature presentation, followed by a question and answers section with panel members.